These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 38745527)

  • 1. Implications of environmental nanoparticles on neurodegeneration.
    Hermosillo-Abundis C; Méndez-Rojas MA; Arias-Carrión O
    J Neurosci Res; 2024 May; 102(5):e25340. PubMed ID: 38745527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The manifestations of toxicity of nanoparticles (a review)].
    Glushkova AV; Radilov AS; Dulov SA
    Gig Sanit; 2011; (2):81-6. PubMed ID: 21598651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanoparticles for Targeted Brain Drug Delivery: What Do We Know?
    Pinheiro RGR; Coutinho AJ; Pinheiro M; Neves AR
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurotoxicity of Titanium Dioxide Nanoparticles: A Comprehensive Review.
    Zhang X; Song Y; Gong H; Wu C; Wang B; Chen W; Hu J; Xiang H; Zhang K; Sun M
    Int J Nanomedicine; 2023; 18():7183-7204. PubMed ID: 38076727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current insights on lipid nanocarrier-assisted drug delivery in the treatment of neurodegenerative diseases.
    Teixeira MI; Lopes CM; Amaral MH; Costa PC
    Eur J Pharm Biopharm; 2020 Apr; 149():192-217. PubMed ID: 31982574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nano-antioxidants: An emerging strategy for intervention against neurodegenerative conditions.
    Sandhir R; Yadav A; Sunkaria A; Singhal N
    Neurochem Int; 2015 Oct; 89():209-26. PubMed ID: 26315960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nano-interventions for neurodegenerative disorders.
    Fernandes C; Soni U; Patravale V
    Pharmacol Res; 2010 Aug; 62(2):166-78. PubMed ID: 20153429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotection by curcumin: A review on brain delivery strategies.
    Askarizadeh A; Barreto GE; Henney NC; Majeed M; Sahebkar A
    Int J Pharm; 2020 Jul; 585():119476. PubMed ID: 32473377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Internal benchmarking of a human blood-brain barrier cell model for screening of nanoparticle uptake and transcytosis.
    Ragnaill MN; Brown M; Ye D; Bramini M; Callanan S; Lynch I; Dawson KA
    Eur J Pharm Biopharm; 2011 Apr; 77(3):360-7. PubMed ID: 21236340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanocarriers for effective nutraceutical delivery to the brain.
    Meenambal R; Srinivas Bharath MM
    Neurochem Int; 2020 Nov; 140():104851. PubMed ID: 32976906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risks from accidental exposures to engineered nanoparticles and neurological health effects: a critical review.
    Simkó M; Mattsson MO
    Part Fibre Toxicol; 2010 Dec; 7():42. PubMed ID: 21176150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biodegradable Nanoparticles for Delivery of Therapeutics in CNS Infection.
    DeMarino C; Schwab A; Pleet M; Mathiesen A; Friedman J; El-Hage N; Kashanchi F
    J Neuroimmune Pharmacol; 2017 Mar; 12(1):31-50. PubMed ID: 27372507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple sclerosis and air pollution exposure: Mechanisms toward brain autoimmunity.
    Esmaeil Mousavi S; Heydarpour P; Reis J; Amiri M; Sahraian MA
    Med Hypotheses; 2017 Mar; 100():23-30. PubMed ID: 28236843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Theranostic applications of nanoparticles in neurodegenerative disorders.
    Ramanathan S; Archunan G; Sivakumar M; Tamil Selvan S; Fred AL; Kumar S; Gulyás B; Padmanabhan P
    Int J Nanomedicine; 2018; 13():5561-5576. PubMed ID: 30271147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intranasal nanoparticulate delivery systems for neurodegenerative disorders: a review.
    Babu SR; Shekara HH; Sahoo AK; Harsha Vardhan PV; Thiruppathi N; Venkatesh MP
    Ther Deliv; 2023 Sep; 14(9):571-594. PubMed ID: 37691577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crossing the Blood-Brain Barrier: A Review on Drug Delivery Strategies for Treatment of the Central Nervous System Diseases.
    Mansor NI; Nordin N; Mohamed F; Ling KH; Rosli R; Hassan Z
    Curr Drug Deliv; 2019; 16(8):698-711. PubMed ID: 31456519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanomedicine and nanotoxicology: the pros and cons for neurodegeneration and brain cancer.
    Catalan-Figueroa J; Palma-Florez S; Alvarez G; Fritz HF; Jara MO; Morales JO
    Nanomedicine (Lond); 2016 Jan; 11(2):171-87. PubMed ID: 26653284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of drug permeability across blood brain barrier using nanoparticles in meningitis.
    Nair KGS; Ramaiyan V; Sukumaran SK
    Inflammopharmacology; 2018 Jun; 26(3):675-684. PubMed ID: 29582240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Artificial apolipoprotein corona enables nanoparticle brain targeting.
    Dal Magro R; Albertini B; Beretta S; Rigolio R; Donzelli E; Chiorazzi A; Ricci M; Blasi P; Sancini G
    Nanomedicine; 2018 Feb; 14(2):429-438. PubMed ID: 29157979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current Strategies for Brain Drug Delivery.
    Dong X
    Theranostics; 2018; 8(6):1481-1493. PubMed ID: 29556336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.